Showing results (161-170 of 234) with videos related to
Sort By:
Pageof 24
International Journal of Molecular Sciences|July 27, 2022
Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate CancerValentina Doldi, Mara Lecchi, Silva Ljevar, et al.Cancer Research|September 1, 2011
TLR9 agonists oppositely modulate DNA repair genes in tumor versus immune cells and enhance chemotherapy effectsMichele Sommariva, Loris De Cecco, Michelandrea De Cesare, et al.European Journal of Medicinal Chemistry|August 7, 2021
Balanced dual acting compounds targeting aromatase and estrogen receptor α as an emerging therapeutic opportunity to counteract estrogen responsive breast cancerJessica Caciolla, Silvia Martini, Angelo Spinello, et al.Biochemical Pharmacology|November 21, 2017
FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical modelsCristina Corno, Simone Stucchi, Michelandrea De Cesare, et al.Journal of Medicinal Chemistry|August 8, 2013
Novel 1H-pyrrolo[2,3-b]pyridine derivative nortopsentin analogues: synthesis and antitumor activity in peritoneal mesothelioma experimental modelsAnna Carbone, Marzia Pennati, Barbara Parrino, et al.Cancer Research|February 27, 2009
miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase CepsilonPaolo Gandellini, Marco Folini, Nicole Longoni, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|March 17, 2017
Synthesis and Superpotent Anticancer Activity of Tubulysins Carrying Non-hydrolysable N-Substituents on TubuvalineMonica Sani, Paolo Lazzari, Marco Folini, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2008
Multiple mechanisms of telomere maintenance exist and differentially affect clinical outcome in diffuse malignant peritoneal mesotheliomaRaffaella Villa, Maria Grazia Daidone, Rosita Motta, et al.Molecular Cancer|January 23, 2010
miR-21: an oncomir on strike in prostate cancerMarco Folini, Paolo Gandellini, Nicole Longoni, et al.Cells|October 7, 2020
Selinexor Sensitizes TRAIL-R2-Positive TNBC Cells to the Activity of TRAIL-R2xCD3 Bispecific AntibodySilvia Martini, Mariangela Figini, Aurora Croce, et al.Pageof 24